Sign In

Karsten Fischer

CEO bei Memo Therapeutics AG

Karsten Fischer is a highly accomplished individual with a diverse background in the fields of biochemistry, healthcare, and finance.

He pursued his education at the prestigious Freie Universität Berlin, where he obtained a PhD in Biochemistry.

Karsten currently holds the position of CEO at Memo Therapeutics AG, showcasing his leadership and management skills.

His extensive experience includes serving as a board member and observer at various organizations such as AYOXXA Biosystems GmbH, Humedics GmbH, Ventaleon GmbH, BiognoSYS AG, Sonetik AG, and Curetis AG.

Prior to his current role, Karsten was a partner at BioMedPartners AG, where he was involved in strategic decision-making and investments in the healthcare sector.

His professional journey also includes roles in equity capital markets, strategic analysis, and sales force excellence at companies like WestLB and sanofi-aventis.

Karsten Fischer's career began with roles as a consultant at McKinsey & Company and an analyst at DVC Deutsche Venture Capital, showcasing his analytical and problem-solving abilities.

With his solid educational background, extensive professional experience, and versatile skill set, Karsten Fischer continues to make significant contributions to the fields of biotechnology, healthcare, and finance.

Karsten Fischer
Add to my network

Location

Zürich Area, Switzerland